Slack reported fiscal second-quarter financial results after markets closed Tuesday showing breakeven earnings and $215.9 million in revenue, compared with consensus estimates for a net loss of $0.03 per share and $209.1 million in…
Lululemon released fiscal second-quarter results after markets closed Wednesday. The company reported $0.74 in earnings per share (EPS) and $902.9 million in revenue, compared with consensus estimates that called for $0.55 in EPS and…
Co-Diagnostics announced Tuesday that it has entered into an agreement with Arches Research to expand Arches' COVID-19 testing services using Co-Diagnostics’ test kit.
Many analysts have said that the market was running hot through August and now may be the time for it to cool off. Despite Tuesday’s pullback, one analyst sees Apple running much higher from…
Continuous intelligence pioneer Sumo Logic expects to price more than 14 million shares to result in an initial public offering valued up to more than $357 million.
Kamada has announced initial interim results from its ongoing midstage coronavirus study of its treatment of COVID-19 patients with pneumonia.
Corbus Pharmaceuticals has reported that its systemic sclerosis study failed to reach the endpoints, and investors were not pleased.
After markets closed Thursday, Broadcom reported fiscal third-quarter earnings per share of $5.40 and revenue of $5.82 billion, compared with consensus estimates of $5.24 in EPS and revenue of $5.76 billion.
On Thursday, Akebia Therapeutics Inc. (NASDAQ: AKBA) announced topline results from the Phase 3 PRO2TECT studies evaluating the safety and efficacy of vadadustat in chronic kidney disease (CKD). Shares were crushed afterward. This is…
Auris Medical has reported topline data from its Phase 2 Travers trial with intranasal betahistine in vertigo.
Conn’s reported mixed fiscal second-quarter financial results and offered no guidance before the markets opened on Thursday.
Cloudera top consensus earnings expectations, but the topline guidance disappointed.
Cybersecurity firm CrowdStrike posted second-quarter earnings per share (EPS) of $0.03 and $199.0 million in revenue. Consensus estimates had called for a net loss of $0.01 per share and $188.54 million in revenue.
JPMorgan has reiterated its Overweight rating on Peloton and raised the price target to a street-high $105.
NBA Hall of Fame inductee Michael Jordan will be joining DraftKings as a special advisor to the board of directors.
Guess reported better than expected fiscal second-quarter financial results before the markets opened on Wednesday.
Jounce Therapeutics Inc. (NASDAQ: JNCE) made a massive gain on Tuesday after the company announced a licensing agreement with Gilead Sciences Inc. (NASDAQ: GILD). This deal is for the discovery and development of novel…
24/7 Wall St. has included some highlights from the Zoom Video Communications earnings report, as well as what analysts are saying about the stock after the fact.
Like many retailers, J.Jill has been brutalized by the COVID-19 crisis and has drawn down on its credit facilities to stay afloat. An update of its financial situation to investors suggests that things may…
Plus Therapeutics shares rallied on Tuesday after an FDA update on its treatment of patients with recurrent glioblastoma.
